In vivo brain imaging of human exposure to nicotine and tobacco

Handbook of Experimental Pharmacology

Volumn 192, Issue , 2009, Pages 145-171

  Sharma, Anil ^a,b   Brody, Arthur L ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CLORGYLINE C 11; DOPAMINE; FLUORODEOXYGLUCOSE F 18; GLUTAMIC ACID; IODINE 125; LEVO DEPRENYL D2 CARBON 11; NICOTINE PATCH; NICOTINIC RECEPTOR ALPHA4; NICOTINIC RECEPTOR BETA2; RADIOLIGAND; TRACER; UNCLASSIFIED DRUG; VARENICLINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR;

ANXIETY; BASAL GANGLION; BRAIN FUNCTION; COGNITION; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG RECEPTOR BINDING; DRUG UPTAKE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; IN VIVO STUDY; IRRITABILITY; MENTAL PERFORMANCE; MOOD; NEUROANATOMY; NEUROIMAGING; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEUS ACCUMBENS; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; REVIEW; THALAMUS; TOBACCO DEPENDENCE; TREATMENT OUTCOME; VISUAL CORTEX; VISUAL SYSTEM; WITHDRAWAL SYNDROME; ANIMAL; BRAIN; DRUG EFFECT; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; SMOKING; SMOKING CESSATION;

ANIMALS; BRAIN; COGNITION; DOPAMINE; HUMANS; NICOTINE; NICOTINIC AGONISTS; RECEPTORS, NICOTINIC; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 63849311570     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-69248-5_6     Document Type: Review

References (181)

1. Alexander GE, Crutcher MD, DeLong MR (1990) Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 85: 119-146
2. Bahk JY, Li SP, Park MS, KimMO(2002) Dopamine D-1 and D-2 receptor mRNA up-regulation in the caudate-putamen and nucleus accumbens of rat brains by smoking. Prog Neuropsychopharmacol Biol Psychiatry 26:1095-1104
3. Baker RR, Massey ED, Smith G (2004) An overview of the effects of tobacco ingredients on smoke chemistry and toxicity. Food Chem Toxicol 42(Suppl):S53-S83
4. Balluz L, Ahluwalia IB, MurphyW, Mokdad A, GilesW, Harris VB (2004) Surveillance for certain health behaviors among selected local areas-United States, Behavioral Risk Factor Surveillance System, 2002. MMWR Surveill Summ 53:1-100
5. 11C] raclopride. Synapse 54:65-71
6. Bartal M (2001) Health effects of tobacco use and exposure. Monaldi Arch Chest Dis 56:545-554
7. Bell SL, Taylor RC, Singleton EG, Henningfield JE, Heishman SJ (1999) Smoking after nicotine deprivation enhances cognitive performance and decreases tobacco craving in drug abusers. Nicotine Tob Res 1:45-52
8. 3H]nicotine binding sites in human brain. J Neurochem 50:1243-1247
9. Berlin I, Anthenelli RM (2001) Monoamine oxidases and tobacco smoking. Int J Neuropsychopharmacol 4:33-42
10. Blaha CD, Allen LF, Das S, Inglis WL, Latimer MP, Vincent SR, Winn P (1996) Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleus-lesioned, and laterodorsal tegmental nucleus-lesioned rats. J Neurosci 16:714-722
11. 3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther 282:7-13
12. Brody AL, Mandelkern MA, London ED, Childress AR, Bota RG, Ho ML, Lee GS, Saxena S, Baxter LR, Madsen D, Jarvik ME (2002) Brain metabolic changes during cigarette craving. Arch Gen Psychiatry 59:1162-1172
13. Brody AL, Mandelkern MA, Lee G, Smith E, Sadeghi M, Saxena S, Jarvik ME, London ED (2004a) Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study. Psych Res Neuroimaging 130:269-281
14. Brody AL, Olmstead RE, London ED, Farahi J, Meyer JH, Grossman P, Lee GS, Huang J, Hahn EL, Mandelkern MA (2004b) Smoking-induced ventral striatum dopamine release. Am J Psychiatry 161:1211-1218
15. Brody AL, Mandelkern MA, London ED, Olmstead RE, Farahi J, Scheibal D, Jou J, Allen V, Tiongson E, Chefer SI, Koren AO, Mukhin AG (2006) Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch Gen Psychiatry 63:907-915
16. Brody AL, Mandelkern MA, Olmstead RE, Jou J, Tiongson E, Allen V, Scheibal D, London ED, Monterosso JR, Tiffany ST, Korb A, Gan JJ, Cohen MS (2007) Neural substrates of resisting craving during cigarette cue exposure. Biol Psychiatry 62:642-651
17. 3H]-nicotine in the mouse brain. Life Sci 44:1123-1132
18. Carter BL, Tiffany ST (1999) Meta-analysis of cue-reactivity in addiction research. Addiction 94:327-340
19. Carter CS, Botvinick MM, Cohen JD (1999) The contribution of the anterior cingulate cortex to executive processes in cognition. Rev Neurosci 10:49-57
20. Chefer SI, Horti AG, Lee K, Koren A, Jones DW, Gorey J, Links JM, Mukhin AG, Weinberger DR, London ED (1998) In vivo imaging of brain nicotinic receptors with 5-[123I]iodo-A-85380 using single photon emission computed tomography. Life Sci 63:PL355-PL360
21. 18F]F-A-83580: a PET radioligand for α4β2 nicotinic acetylcholine receptors. Neuroreport 10:2715-2721
22. Chefer SI, London ED, Koren AO, Pavlova OA, Kurian V, Kimes AS, Horti AG, Mukhin AG (2003) Graphical analysis of 2-[F-18]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain. Synapse 48:25-34
23. Chua P, Krams M, Toni I, Passingham R, Dolan R (1999) A functional anatomy of anticipatory anxiety. Neuroimage 9:563-571
24. Cimino M, Marini P, Fornasari D, Cattabeni F, Clementi F (1992) Distribution of nicotinic receptors in cynomolgus monkey brain and ganglia: localization of alpha 3 subunit mRNA, alphabungarotoxin and nicotine binding sites. Neuroscience 51:77-86
25. Clarke PBS (2004) Nicotinic modulation of thalamocortical neurotransmission. Acetylcholine in the cerebral cortex. Prog Brain Res 145:253-260
26. Clarke PBS, Pert C, Pert A (1984) Autoradiographic distribution of nicotine receptors in rat brain. Brain Res 323:390-395
27. Cohen C, Pickworth WB, Henningfield JE (1991) Cigarette smoking and addiction. Clin Chest Med 12:701-710
28. Connelly MS, Littleton JM (1983) Lack of stereoselectivity in ability of nicotine to release dopamine from rat synaptosomal preparations. J Neurochem 41:1297-1302
29. Corrigall WA, Franklin KB, Coen KM, Clarke PB (1992) The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology 107:285-289
30. Corrigall WA, Coen KM, Adamson KL (1994) Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653:278-284
31. Court JA, Martin-Ruiz C, Graham A, Perry E (2000) Nicotinic receptors in human brain: topography and pathology. J Chem Neuroanat 20:281-298
32. Cousins MS, Roberts DC, de Wit H (2002) GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend 65:209-220
33. Critchley HD, Mathias CJ, Dolan RJ (2001) Neural activity in the human brain relating to uncertainty and arousal during anticipation. Neuroimage 13:S392
34. Cruickshank JM, Neildwyer G, Dorrance DE, Hayes Y, Patel S (1989) Acute effects of smoking on blood-pressure and cerebral blood-flow. J Hum Hypertension 3:443-449
35. Dagher A, Bleicher C, Aston JAD, Gunn RN, Clarke PBS, Cumming P (2001) Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers. Synapse 42:48-53
36. Damsma G, Day J, Fibiger HC (1989) Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens. Eur J Pharmacol 168:363-368
37. 125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors. J Pharmacol Exp Ther 282:445-451
38. Davila-Garcia MI, Houghtling RA, Qasba SS, Kellar KJ (1999) Nicotinic receptor binding sites in rat primary neuronal cells in culture: characterization and their regulation by chronic nicotine. Mol Brain Res 66:14-23
39. Dewey SL, Brodie JD, Gerasimov M, Horan B, Gardner EL, Ashby CRJ (1999) A pharmacologic strategy for the treatment of nicotine addiction. Synapse 31:76-86
40. Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278
41. Ding YS, Volkow ND, Logan J, Garza V, Pappas N, King P, Fowler JS (2000) Occupancy of brain nicotinic acetylcholine receptors by nicotine doses equivalent to those obtained when smoking a cigarette. Synapse 35: 234-237
42. Domino EF, Minoshima S, Guthrie S, Ohl L, Ni L, Koeppe RA, Zubieta JK (2000a) Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers. Synapse 38: 313-321
43. Domino EF, Minoshima S, Guthrie SK, Ohl L, Ni L, Koeppe RA, Cross DJ, Zubieta J (2000b) Effects of nicotine on regional cerebral glucose metabolism in awake resting tobacco smokers. Neuroscience 101:277-282
44. Drevets WC, Price JL, Simpson JR, Jr., Todd RD, Reich T, Vannier M, Raichle ME (1997) Subgenual refrontal cortex abnormalities in mood disorders. Nature 386:824-827
45. Due DL, Huettel SA, Hall WG, Rubin DC (2002) Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. Am J Psychiatry 159:954-960
46. Duncan J, Owen AM (2000) Common regions of the human frontal lobe recruited by diverse cognitive demands. Trends Neurosci 23:475-483
47. Ernst M, Heishman SJ, Spurgeon L, London ED (2001a) Smoking history and nicotine effects on cognitive performance. Neuropsychopharmacology 25:313-319
48. ErnstM,Matochik JA, Heishman SJ, Van Horn JD, Jons PH, Henningfield JE, London ED (2001b) Effect of nicotine on brain activation during performance of a working memory task. Proc Natl Acad Sci USA 98:4728-4733
49. Fallon JH, Keator DB, Mbogori J, Turner J, Potkin SG (2004) Hostility differentiates the brain metabolic effects of nicotine. Brain Res Cogn Brain Res 18:142-148
50. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, Heyman RB, Jaen CR, Kottke TE, Lando HA, Mecklenburg RE, Mullen PD, Nett LM, Robinson L, Stitzer ML, Tommasello AC, Villejo L, Wewers ME (2000) Treating tobacco use and dependence. Clinical Practice Guideline, U.S. Department of Health and Human Services. Public Health Service, Rockville, MD
51. Fowler JS, Volkow ND, Logan J, Wang GJ, MacGregor RR, Schyler D, Wolf AP, Pappas N, Alexoff D, Shea C (1994) Slow recovery of human brain MAO B after L-deprenyl (Selegeline) withdrawal. Synapse 18:86-93
52. Fowler JS, Volkow ND,Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R (1996a) Inhibition of monoamine oxidase B in the brains of smokers. Nature 379:733-736
53. Fowler JS, Volkow ND,Wang GJ, Pappas N, Logan J, Shea C, Alexoff D, MacGregor RR, Schlyer DJ, Zezulkova I,Wolf AP (1996b) Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci USA 93:14065-14069
54. Fowler JS, Volkow ND, Logan J, Pappas N, King P, MacGregor R, Shea C, Garza V, Gatley SJ (1998a) An acute dose of nicotine does not inhibit MAO B in baboon brain in vivo. Life Sci 63:L19-L23
55. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Wolf AP, Warner D, Cilento R, Zezulkova I (1998b) Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition. J Addict Dis 17:23-34
56. Fowler JS, Wang GJ, Volkow ND, Franceschi D, Logan J, Pappas N, Shea C, MacGregor RR, Garza V (1999) Smoking a single cigarette does not produce a measurable reduction in brain MAO B in non-smokers. Nicotine Tob Res 1:325-329
57. Fowler JS, Wang GJ, Volkow ND, Franceschi D, Logan J, Pappas N, Shea C, MacGregor RR, Garza V (2000) Maintenance of brain monoamine oxidase B inhibition in smokers after overnight cigarette abstinence. Am J Psychiatry 157:1864-1866
58. Fowler JS, Logan J, Wang GJ, Volkow ND (2003a) Monoamine oxidase and cigarette smoking. Neurotoxicology 24:75-82
59. Fowler JS, Logan J, Wang GJ, Volkow ND, Telang F, Zhu W, Franceschi D, Pappas N, Ferrieri R, Shea C, Garza V, Xu YW, Schlyer D, Gatley SJ, Ding YS, Alexoff D, Warner D, Netusil N, Carter P, Jayne M, King P, Vaska P (2003b) Low monoamine oxidase B in peripheral organs in smokers. Proc Natl Acad Sci USA 100:11600-11605
60. Fowler JS, Logan J, Wang GJ, Volkow ND, Telang F, Zhu W, Franceschi D, Shea C, Garza V, Xu Y, Ding YS, Alexoff D, Warner D, Netusil N, Carter P, Jayne M, King P, Vaska P (2005) Comparison of monoamine oxidase a in peripheral organs in nonsmokers and smokers. J Nucl Med 46:1414-1420
61. Fowles J, Dybing E (2003) Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob Control 12:424-430
62. Fujita M, Seibyl JP, Vaupel DB, Tamagnan G, Early M, Zoghbi SS, Baldwin RM, Horti AG, Koren AO, Mukhin AG, Khan S, Bozkurt A, Kimes AS, London ED, Innis RB (2002) Whole-body biodistribution, radiation absorbed dose, and brain SPET imaging with [123I]5-I-A-85380 in healthy human subjects. Eur J Nucl Med Mol Imaging 29:183-190
63. Fujita M, Ichise M, van Dyck CH, Zoghbi SS, Tamagnan G, Mukhin AG, Bozkurt A, Seneca N, Tipre D, DeNucci CC, Iida H, Vaupel DB, Horti AG, Koren AO, Kimes AS, London ED, Seibyl JP, Baldwin RM, Innis RB (2003) Quantification of nicotinic acetylcholine receptors in human brain using [I-123]5-I-A-85380 SPET. Eur J Nucl Med Mol Imaging 30:1620-1629
64. Ghatan PH, Ingvar M, Eriksson L, Stone-Elander S, Serrander M, Ekberg K, Wahren J (1998) Cerebral effects of nicotine during cognition in smokers and non-smokers. Psychopharmacology 136:179-189
65. Gioanni Y, Rougeot C, Clarke PB, Lepouse C, Thierry AM, Vidal C (1999) Nicotinic receptors in the rat prefrontal cortex: increase in glutamate release and facilitation of mediodorsal thalamocortical transmission. Eur J Neurosci 11:18-30
66. Goldman-Rakic PS, Leranth C, Williams SM, Mons N, Geffard M (1989) Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc Natl Acad Sci USA 86: 9015-9019
67. Goldstein RZ, Volkow ND (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159:1642-1652
68. Groenewegen HJ, Galis-de Graaf Y, Smeets WJAJ (1999) Integration and segregation of limbic cortico-striatal loops at the thalamic level: an experimental tracing study in rats. J Chem Neuroanat 16:167-185
69. Gross TM, Jarvik ME, RosenblattMR (1993) Nicotine abstinence produces content-specific Stroop interference. Psychopharmacology 110:333-336
70. Haber SN, Fudge JL (1997) The primate substantia nigra and VTA: integrative circuitry and function. Crit Rev Neurobiol 11:323-342
71. Hatsukami D, Fletcher L, Morgan S, Keenan R, Amble P (1989) The effects of varying cigarette deprivation duration on cognitive and performance tasks. J Subst Abuse 1:407-416
72. Herrero MT, Barcia C, Navarro JM (2002) Functional anatomy of thalamus and basal ganglia. Childs Nervous Syst 18:386-404
73. Hogg RC, Raggenbass M, Bertrand D (2003) Nicotinic acetylcholine receptors: from structure to brain function. Rev Physiol Biochem Pharmacol 147:1-46
74. Holmes S, Zwar N, Jimenez-Ruiz CA, Ryan PJ, Browning D, Bergmann L, Johnston JA (2004) Bupropion as an aid to smoking cessation: a review of real-life effectiveness. Int J Clin Pract 58:285-291
75. Horti AG, Scheffel U, Koren AO, Ravert HT, Mathews WB, Musachio JL, Finley PA, London ED, Dannals RF (1998) 2-[F-18]fluoro-A-85380, an in vivo tracer for the nicotinic acetylcholine receptors. Nucl Med Biol 25:599-603
76. 123/125I]iodo-3-(2(S)-azetidinylmethoxy)pyridine: a radioligand for nicotinic acetylcholine receptors. NuclMed Biol 26:175-182
77. Horti AG, Villemagne, VL (2006) The quest for Eldorado: development of radioligands for in vivo imaging of nicotinic acetylcholine receptors in human brain. Curr Pharm Des 12:3877-3900
78. Hughes JR, Lesmes GR, Hatsukami DK, Richmond RL, Lichtenstein E, Jorenby DE, Broughton JO, Fortmann SP, Leischow SJ, McKenna JP, et al (1999) Are higher doses of nicotine replacement more effective for smoking cessation? Nic Tobacco Res 1:169-174
79. Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, KhayrallahMA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. NEJM 337:1195-1202
80. Jacobsen LK, Gore JC, Skudlarski P, Lacadie CM, Jatlow P, Krystal JH (2002) Impact of intravenous nicotine on BOLD signal response to photic stimulation. Magn Reson Imaging 20: 141-145
81. Jacobsen LK, D'Souza DC, MenclWE, Pugh KR, Skudlarski P, Krystal JH (2004) Nicotine effects on brain function and functional connectivity in schizophrenia. Biol Psychiatry 55:850-858
82. Jarvik ME, Madsen DC, Olmstead RE, Iwamoto-Schaap PN, Elins JL, Benowitz NL (2000) Nicotine blood levels and subjective craving for cigarettes. Pharmacol Biochem Behav 66:553-558
83. Jorenby DE, Leischow SJ, NidesMA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. NEJM 340:685-691
84. Kenny PJ, Markou A (2001) Neurobiology of the nicotine withdrawal syndrome. Pharmacol Biochem Behav 70:531-549
85. Killen JD, Fortmann SP, Davis L, Strausberg L, Varady A (1999) Do heavy smokers benefit from higher dose nicotine patch therapy? Exp Clin Psychopharm 7:226-233
86. Killen JD, Fortmann SP, Schatzberg AF, Hayward C, Sussman L, Rothman M, Strausberg L, Varady A (2000) Nicotine patch and paroxetine for smoking cessation. J Consult Clin Psych 68:883-889
87. Kimbrell TA, George MS, Parekh PI, Ketter TA, Podell DM, Danielson AL, Repella JD, Benson BE, Willis MW, Herscovitch P, Post RM (1999) Regional brain activity during transient selfinduced anxiety and anger in healthy adults. Biol Psychiatry 46:454-465
88. 18F]F-A-85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans. FASEB J 17:1331-1333
89. Klimek V, Zhu MY, Dilley G, Konick L, Overholser JC, Meltzer HY, May WL, Stockmeier CA, Ordway GA (2001) Effects of long-term cigarette smoking on the human locus coeruleus. Arch Gen Psychiatry 58:821-827
90. Kodaira K, Fujishiro K, Wada T, Maie K, Satoi T, Tsukiyama E, Fukumoto T, Uchida T, Yamazaki S, Okamura T (1993) A study on cerebral nicotine receptor distribution, blood flow, oxygen consumption, and other metabolic activities-a study on the effects of smoking on carotid and cerebral artery blood flow. Yakubutsu Seishin Kodo 13:157-165
91. Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharm Sci 13:177-184
92. Koren AO, Horti AG, Mukhin AG, Gundisch D, Kimes AS, Dannals RF, London ED (1998) 2-, 5-, and 6-halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling. J Med Chem 41:3690-3698
93. Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K, Ackenheil M (2002) Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder. Int J Neuropsychopharmacol 5:111-113
94. Kubota K, Yamaguchi T, Abe Y, Fujiwara T, Hatazawa J, Matsuzawa T (1983) Effects of smoking on regional cerebral blood-flow in neurologically normal subjects. Stroke 14:720-724
95. Kubota K, Yamaguchi T, Fujiwara T, Matsuzawa T (1987) Effects of smoking on regional cerebral blood-flow in cerebral vascular-disease patients and normal subjects. Tohoku J Exp Med 151:261-268
96. Kumari V, Gray JA, Ffytche DH, Mitterschiffthaler MT, Das M, Zachariah E, Vythelingum GN, Williams SCR, Simmons A, Sharma T (2003) Cognitive effects of nicotine in humans: an fMRI study. Neuroimage 19:1002-1013
97. Lambe EK, Picciotto MR, Aghajanian GK (2003) Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex. Neuropsychopharmacology 28:216-225
98. Lanca AJ, Adamson KL, Coen KM, Chow BL, Corrigall WA (2000) The pedunculopontine tegmental nucleus and the role of cholinergic neurons in nicotine self-administration in the rat: a correlative neuroanatomical and behavioral study. Neuroscience 96:735-742
99. Lawrence NS, Ross TJ, Stein EA (2002) Cognitive mechanisms of nicotine on visual attention. Neuron 36:539-548
100. Leistikow BN, Martin DC, Milano CE (2000a) Estimates of smoking-attributable deaths at ages 15-54, motherless or fatherless youths, and resulting Social Security costs in the United States in 1994. Prev Med 30:353-360
101. Leistikow BN, Martin DC, Milano CE (2000b) Fire injuries, disasters, and costs from cigarettes and cigarette lights: a global overview. Prev Med 31:91-99
102. Leshner AI, Koob GF (1999) Drugs of abuse and the brain. Proc Assoc Am Phys 111:99-108
103. Li SP, Kim KY, Kim JH, Kim JH, Park MS, Bahk JY, Kim MO (2004) Chronic nicotine and smoking treatment increases dopamine transporter mRNA expression in the rat midbrain. Neurosci Lett 363:29-32
104. 3H] nicotine binding sites in the rat brain. Neurosci Lett 53:179-184
105. London ED, Connolly RJ, Szikszay M, Wamsley JK, Dam M (1988a) Effects of nicotine on local cerebral glucose-utilization in the rat. J Neurosci 8:3920-3928
106. London ED, Dam M, Fanelli RJ (1988b) Nicotine enhances cerebral glucose utilization in central components of the rat visual system. Brain Res Bull 20:381-385
107. 3H]epibatidine. Eur J Pharmacol 278:R1-R2
108. Lukas RJ (1998) Neuronal nicotinic acetylcholine receptors. In: Barrantes FJ (ed) The nicotinic acetylcholine receptor: current views and future trends. R.G. Landes, Georgetown, pp 145-173
109. Mansvelder HD, Keath JR, McGehee DS (2002) Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33:905-919
110. Marenco T, Bernstein S, Cumming P, Clarke PBS (2000) Effects of nicotine and chlorisondamine on cerebral glucose utilization in immobilized and freely-moving rats. Br J Pharmacol 129: 147-155
111. Marenco S, Carson RE, Berman KF, Herscovitch P, Weinberger DR (2004) Nicotine-induced dopamine release in primates measured with [C-11]raclopride PET. Neuropsychopharmacology 29:259-268
112. 3H]dopamine from rat brain in vitro: effects of opioids on release induced by potassium, nicotine, and L-glutamic acid. Can J Physiol Pharmacol 61:43-60
113. McClernon FJ, Huettel SA, Rose JE (2005) Abstinence-induced changes in self-report craving correlate with event-related fMRI responses to smoking cues. Neuropsychopharmacology 301:940-1947
114. Miller NS, Goldsmith RJ (2001) Craving for alcohol and drugs in animals and humans: biology and behavior. J Addict Dis 20:87-104
115. Mokdad AH, Marks JS, Stroup DF, Gerberding JL (2004) Actual causes of death in the United States, 2000. JAMA 291:1238-1245
116. Mukhin AG, Gundisch D, Horti AG, Koren AO, Tamagnan G, Kimes AS, Chambers J, Vaupel DB, King SL, Picciotto MR, Innis RB, London ED (2000) 5-Iodo-A-85380, an alpha 4 beta 2 subtype-selective ligand for nicotinic acetylcholine receptors. Mol Pharmacol 57:642-649
117. Naito E, Kinomura S, Geyer S, Kawashima R, Roland PE, Zilles K (2000) Fast reaction to different sensory modalities activates common fields in the motor areas, but the anterior cingulate cortex is involved in the speed of reaction. J Neurophysiol 83:1701-1709
118. Nakamura H, Tanaka A, Nomoto Y, Ueno Y, Nakayama Y (2000) Activation of fronto-limbic system in the human brain by cigarette smoking: evaluated by a CBF measurement. Keio J Med 49(Suppl 1):A122-A124
119. Newhouse PA, Potter A, Singh A (2004) Effects of nicotinic stimulation on cognitive performance. Curr Opin Pharmacol 4:36-46
120. Nisell M, Nomikos GG, Svensson TH (1994) Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse 16:36-44
121. 3H]Cytisine binding to nicotinic cholinergic receptors in brain. Mol Pharmacol 39:9-12
122. Parrott AC (2003) Cigarette-derived nicotine is not a medicine. World J Biol Psychiatry 4:49-55
123. Parrott AC, Kaye FJ (1999) Daily uplifts, hassles, stresses and cognitive failures: in cigarette smokers, abstaining smokers, and non-smokers. Behav Pharmacol 10:639-646
124. Paterson D, Nordberg A (2000) Neuronal nicotinic receptors in the human brain. Prog Neurobiol 61:75-111
125. Paulson OB (2002) Blood-brain barrier, brain metabolism and cerebral blood flow. Eur Neuropsychopharmacol 12:495-501
126. Pauly JR, Stitzel JA, Marks MJ, Collins AC (1989) An autoradiographic analysis of cholinergic receptors in mouse brain. Brain Res Bull 22:453-459
127. Pauly JR, Marks MJ, Robinson SF, van de Kamp JL, Collins AC (1996) Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels. J Pharmacol Exp Ther 278:361-369
128. Perkins K, Sayette M, Conklin C, Caggiula A (2003) Placebo effects of tobacco smoking and other nicotine intake. Nicotine Tob Res 5:695-709
129. 3H]Epibatidine labels nicotinic receptors in rat brain: an autoradiographic study. J Pharmacol Exp Ther 285:1030-1034
130. Pessoa L, Kastner S, Ungerleider LG (2003) Neuroimaging studies of attention: from modulation of sensory processing to top-down control. J Neurosci 23:3990-3998
131. Peterson BS, Skudlarski P, Gatenby JC, Zhang HP, Anderson AW, Gore JC (1999) An fMRI study of Stroop word-color interference: evidence for cingulate subregions subserving multiple distributed attentional systems. Biol Psychiatry 45:1237-1258
132. Picciotto MR, Corrigall WA (2002) Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics. J Neurosci 22:3338-3341
133. Pomper MG, Phillips, E, Fan, H, McCarthy, DJ, Keith, RA, Gordon, JC, Scheffel, U, Dannals, RF, Musachio, JL. (2005) Synthesis and biodistribution of radiolabeled alpha 7 nicotinic acetylcholine receptor ligands. J Nucl Med 46:326-334
134. Pontieri FE, Tanda G, Orzi F, Di Chiara G (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382:255-257
135. Powell J, Dawkins L, Davis RE (2002) Smoking, reward responsiveness, and response inhibition: tests of an incentive motivational model. Biol Psychiatry 51:151-163
136. Pritchard WS, Robinson JH, Guy TD (1992) Enhancement of continuous performance task reaction-time by smoking in nondeprived smokers. Psychopharmacology 108:437-442
137. Rauch SL, Shin LM, Dougherty DD, Alpert NM, Orr SP, Lasko M, Macklin ML, Fischman AJ, Pitman RK (1999) Neural activation during sexual and competitive arousal in healthy men. Psychiatry Res Neuroimaging 91:1-10
138. Rees G, Lavie N (2001) What can functional imaging reveal about the role of attention in visual awareness? Neuropsychologia 39:1343-1353
139. Rogers RL, Meyer JS, Shaw TG, Mortel KF, Hardenberg JP, Zaid RR (1983) Cigarette-smoking decreases cerebral blood-flow suggesting increased risk for stroke. JAMA 250:2796-2800
140. Rolls ET, Baylis LL (1994) Gustatory, olfactory, and visual convergence within the primate orbitofrontal cortex. J Neurosci 14:5437-5452
141. Rolls ET, Critchley HD, Browning A, Hernadi I (1998) The neurophysiology of taste and olfaction in primates, and umami flavor. Ann N Y Acad Sci 855:426-437
142. Rose JE, Behm FM, Westman EC, Mathew RJ, London ED, Hawk TC, Turkington TG, Coleman RE (2003) PET studies of the influences of nicotine on neural systems in cigarette smokers. Am J Psychiatry 160:323-333
143. Rose JE, Behm FM, Salley AN, Bates JE, Coleman RE, Hawk TC (2007) Regional brain activity correlates of nicotine dependence. Neuropsychopharmacology 32:2441-2452
144. Rourke SB, Dupont RM, Grant I, Lehr PP, Lamoureux G, Halpern S, Yeung DW(1997) Reduction in cortical IMP-SPET tracer uptake with recent cigarette consumption in a young group of healthy males. San Diego HIV Neurobehavioral Research Center. Eur J Nucl Med 24:422-427
145. 3H] dopamine release by nicotine in rat nucleus accumbens. J Neurochem 49:1449-1454
146. Rusted JM, Caulfield D, King L, Goode A (2000) Moving out of the laboratory: does nicotine improve everyday attention? Behav Pharmacol 11:621-629
147. Ryan RE, Ross SA, Drago J, Loiacono RE (2001) Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha 4 nicotinic receptor subunit knockout mice. Br J Pharmacol 132:1650-1656
148. 3H]metabolites in rat striatum by nicotinic drugs. Brain Res 242:99-106
149. Salokangas RK, Vilkman H, Ilonen T, Taiminen T, Bergman J, Haaparanta M, Solin O, Alanen A, Syvalahti E, Hietala J (2000) High levels of dopamine activity in the basal ganglia of cigarette smokers. Am J Psychiatry 157:632-634
150. Schilstrom B, Fagerquist MV, Zhang X, Hertel P, Panagis G, Nomikos GG, Svensson TH (2000) Putative role of presynaptic alpha7* nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area. Synapse 38:375-383
151. Schuh KJ, Stitzer ML (1995) Desire to smoke during spaced smoking intervals. Psychopharmacology 120:289-295
152. Sherman SM (2001) Thalamic relay functions. Prog Brain Res 134:51-69
153. Shiffman S, Paty JA, Gnys M, Elash C, Kassel JD (1995) Nicotine withdrawal in chippers and regular smokers - subjective and cognitive effects. Health Psychol 14:301-309
154. Shoaib M, Schindler CW, Goldberg SR, Pauly JR (1997) Behavioural and biochemical adaptations to nicotine in rats: influence of MK801, an NMDA receptor antagonist. Psychopharmacology 134:121-130
155. Shoaib M, Lowe AS, Williams SCR (2004) Imaging localised dynamic changes in the nucleus accumbens following nicotine withdrawal in rats. Neuroimage 22:847-854
156. Sihver W, Langstrom B, Nordberg A (2000) Ligands for in vivo imaging of nicotinic receptor subtypes in Alzheimer brain. Acta Neurol Scand 102:27-33
157. Sillito AM, Jones HE (2002) Corticothalamic interactions in the transfer of visual information. Philos Trans R Soc Lond Ser B Biol Sci 357:1739-1752
158. Smith EE, Jonides J (1999) Neuroscience - Storage and executive processes in the frontal lobes. Science 283:1657-1661
159. Sommer MA (2003) The role of the thalamus in motor control. Curr Opin Neurobiol 13:663-670
160. 123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse 41:275-284
161. Staley JK, Krishnan-Sarin S, Cosgrove KP, Krantzler E, Frohlich E, Perry E, Dubin JA, Estok K, Brenner E, Baldwin RM, Tamagnan GD, Seibyl JP, Jatlow P, Picciotto MR, London ED, O'Malley S, van Dyck CH (2006) Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers. J Neurosci 34:8707-8714
162. Stapleton JM, Gilson SF, Wong DF, Villemagne VL, Dannals RF, Grayson RF, Henningfield JE, London ED (2003a) Intravenous nicotine reduces cerebral glucose metabolism: a preliminary study. Neuropsychopharmacology 28:765-772
163. Stapleton JM, Gilson SF, Wong DF, Villemagne VL, Dannals RF, Grayson RF, Henningfield JE, London ED (2003b) Intravenous nicotine reduces cerebral glucose metabolism: a preliminary study. Neuropsychopharmacology 28:765-772
164. Stein E, Pankiewicz J, Harsch HH, Cho JK, Fuller SA, Hoffmann RG, Hawkins M, Rao S, Bandettini PA, Bloom AS (1998) Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. Am J Psychiatry 155:1009-1015
165. Sziraki I, Lipovac MN, Hashim A, Sershen H, Allen D, Cooper T, Czobor P, Lajtha A (2001) Differences in nicotine-induced dopamine release and nicotine
166. Terborg C, Birkner T, Schack B, Witte OW (2002) Acute effects of cigarette smoking on cerebral oxygenation and hemodynamics: a combined study with near-infrared spectroscopy and transcranial Doppler sonography. J Neurol Sci 205:71-75
167. Thompson JC, Wilby G, Stough C (2002) The effects of transdermal nicotine on inspection time. Hum Psychopharmacol 17:157-161
168. Tsukada H, Miyasato K, Kakiuchi T, Nishiyama S, Harada N, Domino EF (2002) Comparative effects of methamphetamine and nicotine on the striatal [C-11]raclopride binding in unanesthetized monkeys. Synapse 45:207-212
169. Valette H, Bottlaender M, Dolle F, Guenther I, Coulon C, Hinnen F, Fuseau C, Ottaviani M, Crouzel C (1998) Characterization of the nicotinic ligand 2-[F-18]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine in vivo. Life Sci 64:L93-L97
170. Valette H, Bottlaender M, Dolle F, Guenther I, Fuseau C, Coulon C, Ottaviani M, Crouzel C (1999) Imaging central nicotinic acetylcholine receptors in baboons with [F-18]fluoro-A-85380. J Nucl Med 40:1374-1380
171. Valette H, Bottlaender M, Dolle F, Coulon C, Ottaviani M, Syrota A (2003) Long-lasting occupancy of central nicotinic acetylcholine receptors after smoking: a PET study in monkeys. J Neurochem 84:105-111
172. Villemagne V, Horti A, Scheffel U, Ravert H, Finley P, Clough DJ, London E, Wagner H, Dannals RF (1997) Imaging nicotinic acetylcholine receptors with fluorine-18-FPH, an epibatidine analog. J Nucl Med 38:1737-1741
173. Westfall TC, Grant H, Perry H (1983) Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors. Gen Pharmacol 14: 321-325
174. Wilson SJ, Sayette MA, Fiez JA (2004) Prefrontal responses to drug cues: a neurocognitive analysis. Nat Neurosci 7:211-214
175. Yamamoto Y, Nishiyama Y, Monden T, Satoh K, Ohkawa M (2003) A study of the acute effect of smoking on cerebral blood flow using 99mTc-ECD SPET. Eur J Nucl Med Mol Imaging 30:612-614
176. Yates SL, Bencherif M, Fluhler EN, Lippiello PM (1995) Up-regulation of nicotinic acetylcholine receptors following chronic exposure of rats to mainstream cigarette smoke or alpha 4 beta 2 receptors to nicotine. Biochem Pharmacol 50:2001-2008
177. Yeomans J, Baptista M (1997) Both nicotinic and muscarinic receptors in ventral tegmental area contribute to brain-stimulation. Pharmacol Biochem Behav 57:915-921
178. Yoshida M, Yokoo H, Tanaka T, Mizoguchi K, Emoto H, Ishii H, Tanaka M (1993) Facilitatory modulation of mesolimbic dopamine neuronal-activity by a mu-opioid agonist and nicotine as examined with in-vivo microdialysis. Brain Res 624:277-280
179. Zhang X, Tian JY, Svensson AL, Gong ZH, Meyerson B, Nordberg A (2002) Chronic treatments with tacrine and (-)-nicotine induce different changes of nicotinic and muscarinic acetylcholine receptors in the brain of aged rat. J Neural Transm 109:377-392
180. Zubieta J, Lombardi U, Minoshima S, Guthrie S, Ni L, Ohl LE, Koeppe RA, Domino EF (2001) Regional cerebral blood flow effects of nicotine in overnight abstinent smokers. Biol Psychiatry 49:906-913
181. Zubieta JK, Heitzeg MM, Xu Y, Koeppe RA, Ni L, Guthrie S, Domino EF (2005) Regional cerebral blood flow responses to smoking in tobacco smokers after overnight abstinence. Am J Psychiatry 162:567-577